Andre Crawford-Brunt

Andre is an experienced investor and advisor in the technology and biotechnology sectors.  He is a General Partner of Braavos Investment Advisors and serves as board member of Oxford Sciences Innovations, Singapore Biotech, Next Biosciences, Osler, Ultromics and PQShield.  Previously, he spent over 20 years at Deutsche Bank and served as Managing Director, Global Head of Equity Trading.

Andre is also an alumni of Rhodes University and St Johns College, Johannesburg.